Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.

S, Pyrhönen; E, Salminen; M, Ruutu; T, Lehtonen; M, Nurmi; T, Tammela; H, Juusela; E, Rintala; P, Hietanen; PL, Kellokumpu-Lehtinen

doi:10.1200/jco.1999.17.9.2859

Public

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.

Shared by NobleBlocks on Sep 1, 1999 • 12:00 AM UTC

Authors:

Pyrhönen S

Salminen E

Ruutu M

Abstract

Purpose The combination of interferon alfa-2a (IFNalpha2a) plus vinblastine (VLB) induces objective tumor responses in patients with advanced renal cell cancer. However, no prospective randomized trial has shown that this treatment prolongs overall survival. We compared overall survival after treatm...

Discussions